Synergy of KRAS-inhibitor Daraxonrasib Combined With Recombinant Methioninase on Pancreatic-cancer Cells But Not Normal Cells.

Rasonque (daraxonrasib) - Revolution Medicines

ONCase (recombinant methionine α, γ-lyase) - AntiCancer, Shionogi, Nantong Jinghua

http://www.ncbi.nlm.nih.gov/pubmed/42674713

Jinsoo Kim; Michael Bouvet; Qinghong Han; Robert M Hoffman; Shukuan Li; Tomoyuki Ishiguro; Yuta Miyashi

Sep 1, 2026